2019 International Congress Archives - Page 28 of 217

Balance training modulates the concentration of pro- and anti-inflammatory cytokines in the plasma of elder people and PD patients. A pilot study

J. Szymura, J. Kubica, M. Więcek, J. Pera (Krakow, Poland)
Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA

E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)
Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study

G. Nomikos, J. Xiao, M. Yang, V. Irzhevsky (Cambridge, MA, USA)
BeaT-PD, An Industry-Academic Collaboration to Understand PD Progression in Ashkenazi Jews

N. Giladi, A. Orr-Urtreger, M. Gana-Weisz, A. Thaler, O. Goldstein, M. Lalioti, K. Evans, M. Hutchison, O. Mabrouk, A. Dowling, T. Fox, M. Yang, K. Parekh, E. Even Sapir, D. Ben Baast, M. Artzi, H. Lerman, L. Yachimovich, B. Cohen, S. John, A. Mirelman, J. Cederbaum (Tel Aviv, Israel)
BeatPark: a new wearable device for gait auto-rehabilitation in Parkinson’s disease delivering adapted musical stimulation.

V. Cochen Decock, D. Dotov, L. Damm, MC. Picot, P. Ihalainen, V. Driss, C. Geny, B. Bardy, S. Dalla Bella (Montpellier, France)
Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

F. Naz, R. X, YHS. Siddique (Aligarh, India)
Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective

Y. Degirmenci, P. Limousin, GM. Hariz, N. Cakar (Duzce, Turkey)
Beneficial and protective effects of Terminalia chebula in a murine model of Parkinson’s disease

A. Kumar, S. Farhat (New Delhi, India)
Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease

H. Dafsari, S. Jost, A. Sauerbier, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, P. Löhrer, A. Rizos, JN. Petry-Schmelzer, G. Fink, M. Barbe, A. Antonini, P. Martinez-Martin, K. Ray-Chaudhuri, L. Timmermann (Cologne, Germany)
Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease

YH. Lee, JH. Cha, SJ. Chung, HS. Yoo, YH. Sohn, BS. Ye, PH. Lee (Seoul, Republic of Korea)